Auditory sensori-neural alterations induced by salicylate

Progress in Neurobiology

Volumn 62, Issue 6, 2000, Pages 583-631

  Cazals, Yves ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; SALICYLIC ACID;

AUDITORY CORTEX; AUTONOMIC INNERVATION; CHRONIC INFLAMMATION; COCHLEA; COCHLEA BLOOD FLOW; COCHLEA POTENTIAL; COCHLEAR NERVE; DOSE TIME EFFECT RELATION; ELECTROPHYSIOLOGY; EVOKED AUDITORY RESPONSE; HAIR CELL; HEARING; HEARING ACUITY; HEARING LOSS; HISTOPATHOLOGY; HUMAN; INFERIOR COLLICULUS; INNERVATION; NEUROTOXICITY; NOISE; NONHUMAN; OTOTOXICITY; OXIDATIVE PHOSPHORYLATION; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; SENSORY NERVE; SPEECH; TINNITUS;

ADOLESCENT; ADULT; AGED; ANIMALS; AUDITORY THRESHOLD; CHINCHILLA; COCHLEA; FEMALE; HEARING LOSS, HIGH-FREQUENCY; HEARING LOSS, SENSORINEURAL; HEARING TESTS; HUMANS; MALE; MICE; MIDDLE AGED; PITCH PERCEPTION; RATS; SALICYLATES; SPEECH PERCEPTION; TINNITUS;

EID: 0034672939     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(00)00027-7     Document Type: Review

References (211)

1. Abramson S., Weissmann G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Clin. Exp. Rheumatol. 7:(3):1989;S163-S170.
2. Aoyagi M., Yoshida M., Makishima K. Different effects of noise and salicylate and their interactions on the guinea pig cochlea. Eur. Arch. Otorhinolaryngol. 253:1996;429-434.
3. Arruda J., Jung T.T., McGann D.G. Effect of leukotriene inhibitor on otoacoustic emissions in salicylate ototoxicity. Am. J. Otol. 17:1996;787-792.
4. Bancroft B.R., Boettcher F.A., Salvi R.J., Wu J. Effects of noise and salicylate on auditory evoked-response thresholds in the chinchilla. Hear. Res. 54:1991;20-28.
5. Bauer C.A., Brozoski T.J., Rojas R., Boley J., Wyder M. Behavioral model of chronic tinnitus in rats. Otolaryngol. Head Neck Surg. 121:1999;457-462.
6. Bech K. Experimentelle untersuchungen uber den einfluss von bakterietoxienen und giften auf das gehororgan. Zeitschr fur Ohrenheilk und fur khranken der luftwege. 68:1913;128.
7. Bernstein J.M., Weiss A.D. Further observations on salicylate ototoxicity. J. Laryngol. Otol. 81:1967;915-925.
8. Beveridge H.A., Carlyon R.P. Effects of aspirin on human psychophysical tuning curves in forward and simultaneous masking. Hear. Res. 99:1996;110-118.
9. Bian L., Chertoff M.E. Differentiation of cochlear pathophysiology in ears damaged by salicylate or a pure tone using a nonlinear systems identification technique. J. Acoust. Soc. Am. 104:1998;2261-2271.
10. Boettcher F.A., Bancroft B.R., Salvi R.J. Concentration of salicylate in serum and perilymph of the chinchilla. Arch. Otolaryngol. Head Neck Surg. 116:1990;681-684.
11. Boettcher F.A., Bancroft B.R., Salvi R.J., Henderson D. Effects of sodium salicylate on evoked-response measures of hearing. Hear. Res. 42:1989;129-141.
12. Boettcher F.A., Salvi R.J. Salicylate ototoxicity: review and synthesis. Am. J. Otolaryngol. 12:1991;33-47.
13. Bonding P. Critical bandwidth in patients with a hearing loss induced by salicylates. Audiology. 18:1979;133-144.
14. Brennan J.F., Brown C.A., Jastreboff P.J. Salicylate-induced changes in auditory thresholds of adolescent and adult rats. Dev. Psychobiol. 29:1996;69-86.
15. Brien J.A. Ototoxicity associated with salicylates. A brief review. Drug Saf. 9:1993;143-148.
16. Brown A.M., Williams D.M., Gaskill S.A. The effect of aspirin on cochlear mechanical tuning. J. Acoust. Soc. Am. 93:1993;3298-3307.
17. Brownell W.E. Observation on a motile response in isolated outer hair cells. Webster W.R., Aitken L.M. Mechanisms of Hearing. 1983;5-10 Monash University Press.
18. Brownell W.E., Bader C.R., Bertrand D., de Ribaupierre Y. Evoked mechanical responses of isolated cochlear outer hair cells. Science. 227:1985;194-196.
19. Carlyon R.P., Butt M. Effects of aspirin on human auditory filters. Hear. Res. 66:1993;233-244.
20. Carson S.S., Prazma J., Pulver S.H., Anderson T. Combined effects of aspirin and noise in causing permanent hearing loss. Arch. Otolaryngol. Head Neck Surg. 115:1989;1070-1075.
21. Cazals Y., Horner K.C., Huang Z.W. Alterations in average spectrum of cochleoneural activity by long-term salicylate treatment in the guinea pig: a plausible index of tinnitus. J. Neurophysiol. 80:1998;2113-2120.
22. Cazals Y., Huang Z.W. Average spectrum of cochlear activity: a possible synchronized firing, its olivo-cochlear feedback and alterations under anesthesia. Hear. Res. 101:1996;81-92.
23. Cazals Y., Li X.Q., Aurousseau C., Didier A. Acute effects of noradrenalin related vasoactive agents on the ototoxicity of aspirin: an experimental study in the guinea pig. Hear. Res. 36:1988;89-96.
24. Cazals Y., Negrevergne M., Aran J.M. Electrical stimulation of the cochlea in man: hearing induction and tinnitus suppression. J. Am. Audiol. Soc. 3:1978;209-213.
25. Chan E., Ulfendahl M. Mechanically evoked shortening of outer hair cells isolated from the guinea pig organ of Corti. Hear. Res. 128:1999;166-174.
26. Chen C.S., Aberdeen G.C. Potentiation of noise-induced audiogenic seizure risk by salicylate in mice as a function of salicylate-noise exposure interval. Acta Otolaryngol. 90:1980;61-65.
27. Chen G.D., Jastreboff P.J. Salicylate-induced abnormal activity in the inferior colliculus of rats. Hear. Res. 82:1995;158-178.
28. Covell W.P. A cytologic study of the effect of drugs on the cochlea. Arcg. Otolaryngol. 23:1936;633-641.
29. Covell W.P. Effects of drugs on the stria vascularis. Arch. Otolaryngol. 27:1938;438-443.
30. Crifo S. Aspirin ototoxicity in the guinea pig. ORL J. Otorhinolaryngol. Relat. Spec. 37:1975;27-34.
31. Dallos P. The auditory periphery. Biophysics and Physiology. 1973;Academic Press, New York.
32. Dallos P. Neurobiology of cochlear hair cells. Cazals Y., Demany L., Horner K. Auditory Physiology and Perception. 1991;Pergamon Press, Oxford.
33. Dallos P., Popper A.N., Fay R.R. The Cochlea. 1996;Springer, Berlin.
34. Day R.O., Graham G.G., Bieri D., Brown M., Cairns D., Harris G., Hounsell J., Platt-Hepworth S., Reeve R., Sambrook P.N., et al. Concentration-response relationships for salicylate-induced ototoxicity in normal volunteers. Br. J. Clin. Pharmacol. 28:1989;695-702.
35. Deer B.C., Hunter-Duvar I. Salicylate ototoxicity in the chinchilla: a behavioral and electron microscope study. J. Otolaryngol. 11:1982;260-264.
36. Didier A., Droy-Lefaix M.T., Aurousseau C., Cazals Y. Effects of Ginkgo biloba extract (EGb 761) on cochlear vasculature in the guinea pig: morphometric measurements and laser Doppler flowmetry. Eur. Arch. Otorhinolaryngol. 253:1996;25-30.
37. Didier A., Miller J.M., Nuttall A.L. The vascular component of sodium salicylate ototoxicity in the guinea pig. Hear. Res. 69:1993;199-206.
38. Dieler R., Shehata-Dieler W.E., Brownell W.E. Concomitant salicylate-induced alterations of outer hair cell subsurface cisternae and electromotility. J. Neurocytol. 20:1991;637-653.
39. Dieler R., Shehata-Dieler W.E., Richter C.P., Klinke R. Effects of endolymphatic and perilymphatic application of salicylate in the pigeon. II: Fine structure of auditory hair cells. Hear. Res. 74:1994;85-98.
40. Douek E.E., Dodson H.C., Bannister L.H. The effects of sodium salicylate on the cochlea of guinea pigs. J. Laryngol. Otol. 97:1983;793-799.
41. Duan M.L., Canlon B. Outer hair cell activity is not required for the generation of the forward masking curve. Audiol. Neurootol. 1:1996;309-319.
42. Eddy L.B., Morgan R.J., Carney H.C. Hearing loss due to combined effects of noise and salicylate. Biomed. Sci. Instrum. 11:1975;51-55.
43. Eddy L.B., Morgan R.J., Carney H.C. Hearing loss due to combined effects of noise and sodium salicylate. ISA Trans. 15:1976;103-108.
44. Eggermont J.J., Kenmochi M. Salicylate and quinine selectively increase spontaneous firing rates in secondary auditory cortex. Hear. Res. 117:1998;149-160.
45. Escoubet B., Amsallem P., Ferrary E., Tran Ba Huy P. Prostaglandin synthesis by the cochlea of the guinea pig. Influence of aspirin, gentamicin, and acoustic stimulation. Prostaglandins. 29:1985;589-599.
46. Estes W.K., Skinner B.F. Some quantitative properties of anxiety. J. Exp. Psychol. 29:1941;390-400.
47. Evans E.F., Borerwe T.A. Ototoxic effects of salicylates on the responses of single cochlear nerve fibres and on cochlear potentials. Br. J. Audiol. 16:1982;101-108.
48. Evans E.F., Wilson J.P., Borerwe T.A. Animal models of tinnitus. Ciba Found Symp. 85:1981;108-138.
49. Eybalin M., Calas A., Pujol R. Radioautographic study of the symphathetic fibers in the cochlea. Acta Otolaryngol. 96:1983;69-74.
50. Falbe-Hansen, J., 1941. Clinical and experimental histological studies of the effects of salicylates and quinine on the ear. Acta Otolaryngol. (Suppl 44), 1-216.
51. Falk S.A. Letter: sodium salicylate. Arch. Otolaryngol. 99:1974;393.
52. Fay R.R. Hearing in Vertebrates: a Psychophysics Databook. 1988;Hill-Fay Associates, Winnetka, IL.
53. Fitzgerald J.J., Robertson D., Johnstone B.M. Effects of intra-cochlear perfusion of salicylates on cochlear microphonic and other auditory responses in the guinea pig. Hear. Res. 67:1993;147-156.
54. Fletcher B.S., Kujubu D.A., Perrin D.M., Herschman H.R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267:1992;4338-4344.
55. Frank G., Kossl M. The acoustic two-tone distortions 2f1-f2 and f2-f1 and their possible relation to changes in the operating point of the cochlear amplifier. Hear. Res. 98:1996;104-115.
56. Fratianni T., Jung T.T.K., Miller S.K., Vasquez B. Effects of adrenergic blockers on sodium salicylate induced ototoxicity. Otolaryngol. Head and Neck Surg. 103:1990;233.
57. Ghose, R.R., Joekes, A.M., 1964. Treatment of sever aspirin poisoning without dialysis. Lancet i, 1409-1412.
58. Gignoux M., Martin H., Cajgfinger H. Troubles cochléo-vestibulaires après tentative de suicide à l'aspirine. J. Fr. Otorhinolaryngol. Chir Maxillofac. 15:1966;631-635.
59. Gold A., Wilpizeski C.R. Studies in auditory adaptation. II. Some effects of sodium salicylate on evoked auditory potentials in cats. Laryngoscope. 76:1966;674-685.
60. Gotlib I.L. Morphological changes in cell of the cochlear and vestibular analyzers following ingestion of sodium salicylate. Vestn. Otorinolring. 196:1957;31-35.
61. Graham J.D.P., Parker W.A. The toxic manifestations of sodium salicylate therapy. Quart. J. Med. 17:1948;153-163.
62. Gunther T., Rebentisch E., Vormann J. Enhanced ototoxicity of salicylate by magnesium deficiency. Magnesium Bull. 11:1989;15-18.
63. Gunther T., Rebentisch E., Vormann J. Protection against salicylate ototoxicity by zinc. J. Trace Elem. Electrolytes Health Dis. 3:1989;51-53.
64. Gunther T., Rebentisch E., Vormann J., Konig M., Ising H. Enhanced ototoxicity of gentamicin and salicylate caused by Mg deficiency and zinc deficiency. Biol. Trace Element Res. 16:1988;43-50.
65. Halla J.T., Atchison S.L., Hardin J.G. Symptomatic salicylate ototoxicity: a useful indicator of serum salicylate concentration? [see comments]. Ann. Rheum. Dis. 50:1991;682-684.
66. Halla J.T., Hardin J.G. Salicylate ototoxicity in patients with rheumatoid arthritis: a controlled study. Ann. Rheum. Dis. 47:1988;134-137.
67. Hallworth R. Modulation of outer hair cell compliance and force by agents that affect hearing. Hear. Res. 114:1997;204-212.
68. Hawkins J.E. Drug ototoxicity. Keidel W.D., Neff W.D. Handbook of Sensory Physiology. vol. 5, Part 3:1976;Springer, Berlin.
69. Hicks M.L., Bacon S.P. Effects of aspirin on psychophysical measures of frequency selectivity, two-tone suppression, and growth of masking. J. Acoust. Soc. Am. 106:1999;1436-1451.
70. Hunt M.D., Neuenschwander U.H., Delaney T.P., Weymann K.B., Friedrich L.B., Lawton K.A., Steiner H.Y., Ryals J.A. Recent advances in systemic acquired resistance research - a review. Gene. 179:1996;89-95.
71. Ishii T., Bernstein J.M., Balogh K. Jr. Distribution of tritium-labeled salicylate in the cochlea. An autoradiographical study. Ann. Otol. Rhinol. Laryngol. 76:1967;368-376.
72. Jager B.V., Alway R. The treatment of acute rheumatic fever with large doses of sodium salicylate. Am. J. Med. Sci. 211:1946;273-285.
73. Janssen T., Boege P., Oestreicher E., Arnold W. Tinnitus and 2f1-f2 distortion product otoacoustic emissions following salicylate overdose. J. Acouse. Soc. Am. 107:2000;1790-1792.
74. Jardini L., Findlay R., Burgi E., Hinderer K., Agarwal A. Auditory changes associated with moderate blood salicylate levels. Rheumatol. Rehabil. 17:1978;233-236.
75. Jarvis J.F. A case of unilateral permanent deafness following acetylsalicylic acid. J. Laryngol. Otol. 80:1966;318-320.
76. Jastreboff P.J., Brennan J.F., Coleman J.K., Sasaki C.T. Phantom auditory sensation in rats: an animal model for tinnitus. Behav. Neurosci. 102:1988;811-822.
77. Jastreboff P.J., Brennan J.F., Sasaki C.T. Quinine-induced tinnitus in rats. Arch. Otolaryngol. Head Neck Surg. 117:1991;1162-1166.
78. Jastreboff P.J., Hansen R., Sasaki P.G., Sasaki C.T. Differential uptake of salicylate in serum, cerebrospinal fluid, and perilymph. Arch. Otolaryngol. Head Neck Surg. 112:1986;1050-1053.
79. Jastreboff P.J., Issing W., Brennan J.F., Sasaki C.T. Pigmentation, anesthesia, behavioral factors, and salicylate uptake. Arch. Otolaryngol. Head Neck Surg. 114:1988;186-191.
80. Jastreboff P.J., Jastreboff M.M., Kwon O., Shi J., Hu S. An animal model of noise induced tinnitus. Hazell J. Sixth International Tinnitus Seminar. 1999;198-202 Hawthorn, Cambridge.
81. Jastreboff P.J., Sasaki C.T. Salicylate-induced changes in spontaneous activity of single units in the inferior colliculus of the guinea pig. J. Acoust. Soc. Am. 80:1986;1384-1391.
82. Jastreboff P.J., Sasaki C.T. An animal model of tinnitus: a decade of development. Am. J. Otol. 15:1994;19-27.
83. Johnsen N.J., Elberling C. Evoked acoustic emissions from the human ear. I. Equipment and response parameters. Scand. Audiol. 11:1982;3-12.
84. Johnson A.C. Auditory sensitivity in rats exposed to toluene and/or acetyl salicylic acid. NeuroReport. 3:1992;1141-1144.
85. Jordan C.E. Case history: asking the right questions. Ear Hear. 12:1991;363-364.
86. Juhn S.K., Rybak L.P., Jung T.T.K. Transport characteristics of the blood labyrinthine barrier. Drescher D. Auditory Biochemistry. 1985;488-499 Thomas CC, Springfield.
87. Jung T.T., Hwang A.L., Miller S.K., Rhee C.K., Park Y.S. Effect of leukotriene inhibitor on cochlear blood flow in salicylate ototoxicity. Acta Otolaryngol. (Stockh.). 115:1995;251-254.
88. Jung T.T., Kim J.P., Bunn J., Davamony D., Duncan J., Fletcher W.H. Effect of leukotriene inhibitor on salicylate induced morphologic changes of isolated cochlear outer hair cells. Acta Otolaryngol. (Stockh.). 117:1997;258-264.
89. Jung, T.T., Miller, S.K., Rozehnal, S., Woo, H.Y., Park, Y.M., Baer, W., 1992. Effect of round window membrane application of salicylate and indomethacin on hearing and levels of arachidonic acid metabolites in perilymph. Acta Otolaryngol. (Suppl. 493), 81-87.
90. Jung, T.T., Park, Y.M., Miller, S.K., Rozehnal, S., Woo, H.Y., Baer, W., 1992. Effect of exogenous arachidonic acid metabolites applied on round window membrane on hearing and their levels in the perilymph. Acta Otolaryngol. (Suppl. 493), 171-176.
91. Jung T.T., Rhee C.K., Lee C.S., Park Y.S., Choi D.C. Ototoxicity of salicylate, nonsteroidal antiinflammatory drugs, and quinine. Otolaryngol. Clin. North Am. 26:1993;791-810.
92. Jung, T.T.K., Juhn, S.K., 1984. Prostaglandisn in the perilymph. Ass. Res. Otolaryngology Abs. 107.
93. Jung, T.T.K., Kim, P.S., Kim, D.H., Miller, S.K., Vasquez, B., 1990. Effects of sodium salicylate on levels of catecholamines in the perilymph. Ass. Res. Otolaryngology Abs. 52.
94. Kakehata S., Santos-Sacchi J. Effects of salicylate and lanthanides on outer hair cell motility and associated gating charge. J. Neurosci. 16:1996;4881-9489.
95. Kaltenbach J.A., Heffner H.E., Afman C.E. Effects of intense sound on spontaneous activity in the dorsal cochlear nucleus and its relation to tinnitus. Hazell J. Sixth International Tinnitus Seminar. 1999;Hawthorn, Cambridge.
96. Kapur Y.P. Ototoxicity of acetylsalicylic acid. Arch. Otolaryngol. 81:1965;134-138.
97. Kay I.S., Davies W.E. The effect of nimodipine on salicylate ototoxicity in the rat as revealed by the auditory evoked brain-stem response. Eur. Arch. Otorhinolaryngol. 250:1993;51-54.
98. Kemp D.T. Stimulated acoustic emissions from within the human auditory system. J. Acoust. Soc. Am. 64:1978;1386-1391.
99. Kenmochi M., Eggermont J.J. Salicylate and quinine affect the central nervous system. Hear. Res. 113:1997;110-116.
100. Khanna S.M., Leonard D.G. Basilar membrane tuning in the cat cochlea. Science. 215:1982;305-306.
101. Kirchner W. Extravasate im labyrinth durch chinin und salicylwirkung. Mschr. Ohrenheilk. 17:1883;85.
102. Koegel L. Jr. Ototoxicity: a contemporary review of aminoglycosides, loop diuretics, acetylsalicylic acid, quinine, erythromycin, and cisplatinum. Am. J. Otol. 6:1985;190-199.
103. Krzanowski J.J. Jr., Matschinsky F.M. A phosphocreatine gradient opposite to that of glycogen in the organ of Corti and the effect of salicylate on adenosine triphosphate and P-creatine in cochlear structures. J. Histochem. Cytochem. 19:1971;321-323.
104. Krzanowski J.J. Jr., Matschinsky F.M. Adenosine triphosphate and phosphocreatine levels in cochlear structures. Use rate and effect of salicylates. J. Histochem. Cytochem. 23:1975;766-773.
105. Kujawa S.G., Fallon M., Bobbin R.P. Intracochlear salicylate reduces low-intensity acoustic and cochlear microphonic distortion products. Hear. Res. 64:1992;73-80.
106. Kumagai M. Effect of intravenous injection of aspirin on the cochlea. Hokkaido Igaku Zasshi. 67:1992;216-233.
107. Kurata K., Yamamoto M., Tsukuda R., Suzuki T., Sato S. A characteristic of aspirin-induced hearing loss in auditory brainstem response of conscious rats. J. Vet. Med. Sci. 59:1997;9-15.
108. Lambert P.R., Palmer P.E., Rubel E.W. The interaction of noise and aspirin in the chick basilar papilla. Noise and aspirin toxicity. Arch. Otolaryngol. Head Neck Surg. 112:1986;1043-1049.
109. Laurikainen E.A., Costa O., Miller J.M., Nuttall A.L., Ren T.Y., Masta R., Quirk W.S., Robinson P.J. Neuronal regulation of cochlear blood flow in the guinea-pig. J. Physiol. (Lond.). 480:1994;563-573.
110. Levy G.N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J. 11:1997;234-247.
111. Lindgren, F., Axelsson, A., 1986. Temporary threshold shift induced by noise exposure and moderate salicylate intake. Scand. Audiol. (Suppl. 26), 41-44.
112. Lindt W. Experimentelle untersuchungen uber den einfuluss des chinins und ntrium salicylate auf das gehororgan der tiere. Veh Dtisch Naturdorsch Arzte. 2:1913;826.
113. Long G. Perceptual consequences of the interactions between spontaneous otoacoustic emissions and external tones. I. Monaural diplacusis and aftertones. Hear. Res. 119:1998;49-60.
114. Long G.R., Tubis A. Investigations into the nature of the association between threshold microstructure and otoacoustic emissions. Hear. Res. 36:1988;125-138.
115. Long G.R., Tubis A. Modification of spontaneous and evoked otoacoustic emissions and associated psychoacoustic microstructure by aspirin consumption. J. Acoust. Soc. Am. 84:1988;1343-1353.
116. Long G.R., Tubis A., Jones K.L. Modeling synchronization and suppression of spontaneous otoacoustic emissions using Van der Pol oscillators: effects of aspirin administration. J. Acoust. Soc. Am. 89:1991;1201-1212.
117. Lucente F.E. Aspirin and the otolaryngologist. Arch. Otolaryngol. 94:1971;443-446.
118. Lue A.J.-C. Salicylate induced changes in outer hair cell lateral wall stiffness. Hear. Res. 135:1999;163-168.
119. Lurie M.H. Animal experimentation on hearing: its clues to the prevention of deafness. Trans. Am. Acad. Ophthalm. 40:1935;375-389.
120. Mammano F., Ashmore J.F. Reverse transduction measured in the isolated cochlea by laser Michelson interferometry. Nature. 365:1993;838-841.
121. Manabe Y., Saito T., Saito H. Effects of lidocaine on salicylate-induced discharge of auditory neurons in the inferior colliculus of the guinea pig. Nippon Jibiinkoka Gakkai Kaiho. 101:1998;807-813.
122. Mantz J.M., Haegy J.M., Tempe J.D., Jaeger A. Acute aspirin poisoning in adults. Rev. Prat. 28:1978;4557-4562.
123. Martin G.K., Lonsbury-Martin B.L., Probst R., Coats A.C. Spontaneous otoacoustic emissions in a nonhuman primate. I. Basic features and relations to other emissions. Hear. Res. 33:1988;49-68.
124. Martin W.H. Spectral analysis of brain activity in the study of tinnitus. Vernon J.A., Moller A.R. Mechanisms of Tinnitus. 1994;163-180 Allyn and Bacon, Boston.
125. Martin W.H., Schwegler J.W., Scheibelhoffer J., Ronis M.L. Salicylate-induced changes in cat auditory nerve activity. Laryngoscope. 103:1993;600-604.
126. Martin W.H., Schwegler J.W., Shi Y., Pratt H., Adler S. Developing an objective measurement tool for evaluating tinnitus: spectral averaging. Reich G.E., Vernon J.A. Proceedings of 5th International Tinnitus Seminar. 1996;127-133 American Tinnitus Association, Portland, Oregon.
127. Matsuura S., Ikeda K., Furukawa T. Effects of streptomycin, kanamycin, quinine, and other drugs on the microphonic potentials of goldfish sacculus. Jpn. J. Physiol. 21:1971;579-590.
128. McCabe P.A., Dey F.L. The effect of aspirin upon auditory sensitivity. Ann. Otol. Rhinol. Laryngol. 74:1965;312-324.
129. McFadden D., Champlin C.A. Reductions in overshoot during aspirin use. J. Acoust. Soc. Am. 87:1990;2634-2642.
130. McFadden D., Plattsmier H.S. Aspirin can potentiate the temporary hearing loss induced by intense sounds. Hear. Res. 9:1983;295-316.
131. McFadden D., Plattsmier H.S. Aspirin abolishes spontaneous oto-acoustic emissions. J. Acoust. Soc. Am. 76:1984;443-448.
132. McFadden D., Plattsmier H.S., Pasanen E.G. Aspirin-induced hearing loss as a model of sensorineural hearing loss. Hear. Res. 16:1984;251-260.
133. McFadden D., Plattsmier H.S., Pasanen E.G. Temporary hearing loss induced by combinations of intense sounds and nonsteroidal anti-inflammatory drugs. Am. J. Otolaryngol. 5:1984;235-241.
134. McPherson D.L., Miller J.M. Choline salicylate. Effects on cochlear function. Arch. Otolaryngol. 99:1974;304-308.
135. Miners J.O. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid. Clin. Pharmacokinet. 17:1989;327-344.
136. Mitchell C., Brummett R., Himes D., Vernon J. Electrophysiological study of the effect of sodium salicylate upon the cochlea. Arch. Otolaryngol. 98:1973;297-301.
137. Mongan E., Kelly P., Nies K., Porter W.W., Paulus H.E. Tinnitus as an indication of therapeutic serum salicylate levels. Jama. 226:1973;142-145.
138. Mosher H.P. Does animal experimentation show similar changes in ear of mother and fetus after ingestion of quinine by mother? Laryngoscope. 48:1938;361-395.
139. Mulheran M. The effects of quinine on cochlear nerve fiber activity in the guinea pig. Hear. Res. 134:1999;145-152.
140. Müller G. Beitrag zur wirking der salicylasuren natrons beim diabetes mellus. Ber. Clin. Wochensch. 14:1877;29-31.
141. Murphy W.J., Tubis A., Talmadge C.L., Long G.R. Relaxation dynamics of spontaneous otoacoustic emissions perturbed by external tones. II. Suppression of interacting emissions. J. Acoust. Soc. Am. 97:1995;3711-3720.
142. Murugasu E., Russell I.J. Salicylate ototoxicity: the effects on basilar membrane displacement, cochlear microphonics and neural responses in the basal turn of the guinea pig cochlea. Auditory Neuroscience. 1:1995;139-150.
143. Myers E.N., Bernstein J.M. Salicylate ototoxicity; a clinical and experimental study. Arch. Otolaryngol. 82:1965;483-493.
144. Myers E.N., Bernstein J.M., Fostiropolous G. Salicylate ototoxicity, a clinical study. New Engl. J. Med. 273:1965;587-590.
145. Needs C.J., Brooks P.M. Clinical pharmacokinetics of the salicylates. Clin. Pharmacokinet. 10:1985;164-177.
146. Nenov A.P., Skellett R.A., Fallon M., Bobbin R.P. Nitrosoglutathione suppresses cochlear potentials and DPOAEs but not outer hair cell currents or voltage-dependent capacitance. Hear. Res. 110:1997;77-86.
147. Ochi K., Eggermont J.J. Effects of salicylate on neural activity in cat primary auditory cortex. Hear. Res. 95:1996;63-76.
148. Ohlsen K.A., Baldwin D.L., Nuttall A.L., Miller J.M. Influence of topically applied adrenergic agents on cochlear blood flow. Circ. Res. 69:1991;509-518.
149. Oliveira J.A., Marseillan R.F. Toxicité du salicylate de soude sur le labyrinthe du cobaye. Rev. Laryngol. 97:1976;17-34.
150. Oudot J., Pignat J.C., Martin H. Intoxication aigue à l'aspirine et surdité. A propos de 10 cas. J. Fr. Otorhinolaryngol. Audiophonol. Chir Maxillofac. 28:1979;687-693.
151. Park Y.S., Jung T.T., Choi D.J., Rhee C.K. Effect of corticosteroid treatment on salicylate ototoxicity. Ann. Otol. Rhinol. Laryngol. 103:1994;896-900.
152. Patuzzi R. Cochlear micromechanics and macromechanics. Dallos P., Popper A.N., Fay R.R. The Cochlea. vol. SHAR 8:1996;196-257 Springer, Berlin.
153. Pedersen C.B. Brief-tone audiometry in persons treated with salicylate. Audiology. 13:1974;311-319.
154. Penner M.J. Aspirin abolishes tinnitus caused by spontaneous otoacoustic emissions. A case study. Arch. Otolaryngol. Head Neck Surg. 115:1989;871-875.
155. Penner M.J., Coles R.R. Indications for aspirin as a palliative for tinnitus caused by SOAEs: a case study. Br. J. Audiol. 26:1992;91-96.
156. Penner M.J., Jastreboff P.J. Tinnitus: psychophysical observations in humans and an animal model. van de Water T.R., Popper A.N., Fay R.R. Clinical Aspects of Hearing. 1996;258-304 Springer, Berlin.
157. Perez de Moura L.F., Hayden R.C. Jr. Salicylate ototoxicity. A human temporal bone report. Arch. Otolaryngol. 87:1968;368-372.
158. Perlman L.V. Salicylate intoxication from skin application. New Engl. J. Med. 274:1966;164.
159. PharminfoNet, 1994. America's 80 billion aspirin habit. Medical Sciences Bulletin on Internet, March.
160. PharminfoNet, 1999. An aspirin a day... just another cliche? Medical Sciences Bulletin on Internet April.
161. Pohlman A.G., Krantz F.W. On effect of certain drugs, notably quinine, on acuity of hearing. Proc. Soc. Exp. Biol. Med. 20:1922;140.
162. Pollice P.A., Brownell W.E. Characterization of the outer hair cell's lateral wall membranes. Hear. Res. 70:1993;187-196.
163. Puel J.L., Bledsoe S.C. Jr., Bobbin R.P., Ceasar G., Fallon M. Comparative actions of salicylate on the amphibian lateral line and guinea pig cochlea. Comp. Biochem. Physiol. C 93:1989;73-80.
164. Puel J.L., Bobbin R.P., Fallon M. Salicylate, mefenamate, meclofenamate, and quinine on cochlear potentials. Otolaryngol. Head Neck Surg. 102:1990;66-73.
165. Quaranta A., Portalatini P., Camporeale M., Sallustio V. Effects of salicylates on evoked otoacoustic emissions and remote masking in humans. Audiology. 38:1999;174-179.
166. Ramsden R.T., Latif A., O'Malley S. Electrocochleographic changes in acute salicylate overdosage. J. Laryngol. Otol. 99:1985;1269-1273.
167. Romeis T., Piedras P., Zhang S., Klessig D.F., Hirt H., Jones J.D. Rapid Avr9- and Cf-9 -dependent activation of MAP kinases in tobacco cell cultures and leaves: convergence of resistance gene, elicitor, wound, and salicylate responses. Plant Cell. 11:1999;273-287.
168. Russell I.J., Schauz C. Salicylate ototoxicity: effects on stiffness and electromotility of outer hair cells isolated from the guinea pig cochlea. Auditory Neuroscience. 1:1995;309-319.
169. Rybak L.P., Santiago W., Whitworth C. An experimental study using sodium salicylate to reduce cochlear changes induced by furosemide. Arch. Otorhinolaryngol. 243:1986;180-182.
170. Rybak L.P., Weberg A., Whitworth C., Scott V. Effects of organic acids on stria vascularis ultrastructure and function in the chinchilla. Eur. Arch. Otorhinolaryngol. 249:1992;168-171.
171. Rybak L.P., Whitworth C. Some organic acids attenuate the effects of furosemide on the endocochlear potential. Hear. Res. 26:1987;89-93.
172. Rybak L.P., Whitworth C., Scott V. Organic acids do not alter the cochlear effects of ethacrynic acid. Hear. Res. 46:1990;95-99.
173. Rybak L.P., Whitworth C., Weberg A., Scott V. Effects of organic acids on the edema of the stria vascularis induced by furosemide. Hear. Res. 59:1992;75-84.
174. Schreiner C.E., Snyder R.L. A physiological animal model of peripheral tinnitus. Feldmann H. Third International Tinnitus Seminar. 1987;100-106 Harsch, Karlsrhue, Germany.
175. Schroder E., Hinsberg H. Zur frage derspeziellen wierkungvon chinin uf das ganglion spirale. Zeitschr fur Ohrenheilk und fur khranken der luftwege. 73:1915;65.
176. Schwabach. Ueber Bleibende Storungen im Gehororgan nach chinin- und salicylsaure-gebrauch. Dtsch. Med. Wochenschr. 10:1984.
177. Sellick P.M., Patuzzi R., Johnstone B.M. Measurement of basilar membrane motion in the guinea pig using the Mossbauer technique. J. Acoust. Soc. Am. 72:1982;131-141.
178. Sée G. Etudes sur I'acide salicylique et les salicylates; traitement du rhumatisme aigu et chronique de la goutte, et de diverses affections du systé nerveux sensitif par les salicylates. Bulletin de l'Académie Nationale de Médecine (Paris). 26:1877;689-706.
179. Sha S.H., Schacht J. Salicylate attenuates gentamicin-induced ototoxicity. Lab. Invest. 79:1999;807-813.
180. Shehata W.E., Brownell W.E., Dieler R. Effects of salicylate on shape, electromotility and membrane characteristics of isolated outer hair cells from guinea pig cochlea. Acta Otolaryngol. 111:1991;707-718.
181. Shehata-Dieler W.E., Richter C.P., Dieler R., Klinke R. Effects of endolymphatic and perilymphatic application of salicylate in the pigeon. Part I: Single fiber activity and cochlear potentials. Hear. Res. 74:1994;77-84.
182. Silverstein H., Bernstein J.M., Davies D.G. Salicylate ototoxicity. A biochemical and electrophysiological study. Ann. Otol. Rhinol. Laryngol. 76:1967;118-128.
183. Spoendlin H., Lichtensteiger W. The adrenergic innervation of the labyrinth. Acta Otolaryngol. 61:1966;423-434.
184. Spongr V.P., Boettcher F.A., Saunders S.S., Salvi R.J. Effects of noise and salicylate on hair cell loss in the chinchilla cochlea. Arch. Otolaryngol. Head Neck Surg. 118:1992;157-164.
185. Stebbins W.C., Clark W.W., Pearson R.D., Weiland N.G. Noise- and drug-induced hearing loss in monkeys. Adv. Otorhinolaryngol. 20:1973;42-63.
186. Stewart C.E., Hudspeth A.J. Effects of salicylates and aminoglycosides on spontaneous otoacoustic emissions in the Tokay gecko. Proc. Natl. Acad. Sci. USA. 97:2000;454-459.
187. Stypulkowski P.H. Mechanisms of salicylate ototoxicity. Hear. Res. 46:1990;113-145.
188. Takahashi S.T., Ohyama K.O., Ikeda K.I., Wada H.W. Salicylate effects on the distortion products in live guinea pig cochlea. Association for Research in Otolaryngology. vol. B:1999;131.
189. Tanaka Y., Brown P.G. Action of metabolic inhibitors and energy-rich phosphate compounds on cochlear potentials. Ann. Otol. Rhinol. Laryngol. 79:1970;338-351.
190. Thalmann R., Miyoshi T., Kusakari J., Thalmann I. Quantitative approaches to the ototoxicity problem. Audiology. 12:1973;364-382.
191. Thomma B., Eggermont K., Penninckx I., Mauch-Mani B., Vogelsang R., Cammue B.P.A., Broekaert W.F. Separate jasmonate-dependent and salicylate-dependent defense- response pathways in arabidopsis are essential for resistance to distinct microbial pathogens [in process citation]. Proc. Natl. Acad. Sci. USA. 95:1998;15107-15111.
192. Tran Ba Huy P., Ferrary E., Escoubet B., Sterkers O. Strial prostaglandins and leukotrienes. Biochemical characteristics and interrelationship with furosemide. Acta Otolaryngol. (Stockh.). 103:1987;558-566.
193. Tunstall M.J., Gale J.E., Ashmore J.F. Action of salicylate on membrane capacitance of outer hair cells from the guinea-pig cochlea. J. Physiol. (Lond.). 485:1995;739-752.
194. Ueda H., Yamamoto Y., Yanagita N. Effect of aspirin on transiently evoked otoacoustic emissions in guinea pigs. ORL J. Otorhinolaryngol. Relat. Spec. 58:1996;61-67.
195. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 231:1971;232-235.
196. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Ann. Rev. Pharmacol. Toxicol. 38:1998;97-120.
197. Vane J.R., Botting R.M. Anti-inflammatory drugs and their mechanism of action. Inflamm. Res. 47:(2):1998;S78-S87.
198. Wallhausser-Franke E. Salicylate evokes c-fos expression in the brain stem: implications for tinnitus. NeuroReport. 8:1997;725-728.
199. Wallhausser-Franke E., Braun S., Langner G. Salicylate alters 2-DG uptake in the auditory system: a model for tinnitus? NeuroReport. 7:1996;1585-1588.
200. Waltner J.G. The effects of salicylates on the inner ear. Ann. Otol. 64:1955;617-622.
201. Wangemann P., Schacht J. Homeostatic mechanisms in the cochlea. Dallos P., Popper A.N., Fay R.R. The Cochlea Springer Handbook of Auditory Research. vol. 8:1996;Springer, Berlin.
202. Weiss J.F., Lever W.F. Percutaneous salicylic acid intoxication in psoriasis. Arch. Dermatol. 90:1964;614-619.
203. Whitehead M.L., Lonsbury-Martin B.L., Martin G.K., McCoy M.J. Otoacoustic emissions: animal models and clinical observations. van de Water T.R., Popper A.N., Fay R.R. Clinical Aspects of Hearing. vol. SHAR 7:1996;199-257 Springer, Berlin.
204. Wier C.C., Pasanen E.G., McFadden D. Partial dissociation of spontaneous otoacoustic emissions and distortion products during aspirin use in humans. J. Acoust. Soc. Am. 84:1988;230-237.
205. Wilson J.P. Cochlear mechanics. Cazals Y., Demany L., Horner K. Auditory Physiology and Perception. 1991;Pergamon Press, Oxford.
206. Wittmaack K. Der angriffspunkt des chinins in nervenssytem des gehororganes. Pflueger Arch. Ges. Physiol. 95:1903;234.
207. Woodford C.M., Henderson D., Hamernik R.P. Effects of combinations of sodium salicylate and noise on the auditory threshold. Ann. Otol. Rhinol. Laryngol. 87:1978;117-127.
208. Wu M., Santos-Sacchi J. Effects of lipophilic ions on outer hair cell membrane capacitance and motility. J. Membr. Biol. 166:1998;111-118.
209. Xie W.L., Chipman J.G., Robertson D.L., Erikson R.L., Simmons D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA. 88:1991;2692-2696.
210. Young L.L. Jr., Wilson K.A. Effects of acetylsalicylic acid on speech discrimination. Audiology. 21:1982;342-349.
211. Zheng J.L., Gao W.Q. Differential damage to auditory neurons and hair